MSP Recovery, Inc. Announces Conclusion of SEC Investigation: No Intention to Recommend Enforcement Action Against the Company, its CEO, John H. Ruiz, or its Officers

11.76%

-38.46%

MIAMI, FLORIDA / ACCESS Newswire / December 7, 2025 / MSP Recovery, Inc. (the "Company"), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, announces that the staff of the U.S. Securities and Exchange Commission ("SEC") has informed the Company that it has concluded its investigation relating to MSP Recovery, Inc., and does not intend to recommend enforcement action to the Commission against the Company, its CEO, John H. Ruiz, or its officers.

As previously disclosed, on August 11, 2022, the SEC initiated an investigation of the Company, and requested documents relating to, among other matters, the Business Combination transaction with Lionheart Acquisition Corporation II, consummated on May 23, 2022, certain historical and projected financial results, investor agreements, and data analytic platforms and algorithms. The Company and certain key personnel received subpoenas during the course of the investigation seeking information regarding, among other things, the Company's projections and the accounting and valuation of certain assets that were the basis for the Company's determination that its quarterly financial statements for the periods ended June 30, 2022 and September 30, 2022 require restatements and should no longer be relied upon, certain funding sources of the Company prior to the Business Combination, various statements and disclosures by the Company in connection with, and following the Business Combination, certain historical and projected financial results, and data analytic platforms and algorithms used to identify potential recoveries.

The Company fully cooperated with the SEC, responding to subpoenas and information requests, and devoted significant resources to providing regulators with data, documents, and access to personnel. Chairman and CEO John H. Ruiz stated, "From day one, MSP Recovery cooperated fully with regulators and let the facts speak for themselves. We are pleased that after reviewing extensive information over more than three years, the SEC staff has concluded its investigation without recommending enforcement action against the Company or its officers. MSP Recovery can now continue its mission without the burdensome costs, time and resources associated with an SEC investigation."

About MSP Recovery, Inc.

Founded in 2014, MSP Recovery has become a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery leader, disrupting the antiquated healthcare reimbursement system with data-driven solutions to secure recoveries from responsible parties. MSP Recovery innovates technologies and provides comprehensive solutions for multiple industries including healthcare and legal. For more information, visit: msprecovery.com.

Forward‑Looking Statements

This release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan," and "will" or, in each case, their negative, or other variations or comparable terminology. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance or results and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by MSP Recovery herein speaks only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for the Company to predict or identify all such events or how they may affect it. MSP Recovery has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to, the SEC changing its position on the outcome of its investigation of the Company, and those risk factors included in MSP Recovery's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by it with the Securities and Exchange Commission. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

Contact: Media@msprecovery.com

SOURCE: MSP Recovery, Inc.

View the original press release on ACCESS Newswire

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

MSPR: Severe revenue decline, mounting losses, and delisting risk threaten ongoing operations

Quartr

11.76%

-38.46%

Revenue fell 95% year-over-year in Q3 2025, with a net loss of $245.5 million and ongoing liquidity concerns. The company faces delisting from Nasdaq, relies on Yorkville SEPA for funding, and has substantial debt and legal risks.

Original document: MSP Recovery, Inc. [MSPR] SEC 10-Q Quarterly Report — Nov. 27 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

Add to Favorites

Dj Msp Recovery Inc Cl A, Inst Holders, 3Q 2025 (Mspr)

Reuters

Risk Warnings and Disclaimers

Add to Favorites

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.18%

Investing.com

Investing.com – U.S. stocks were mixed after the close on Tuesday, as gains in the Healthcare, Telecoms and Oil & Gas sectors led shares higher while losses in the Technology, Industrials and Utilities sectors led shares lower.

At the close in NYSE, the Dow Jones Industrial Average gained 1.18% to hit a new all time high, while the S&P 500 index gained 0.21%, and the NASDAQ Composite index declined 0.25%.

The best performers of the session on the Dow Jones Industrial Average were Merck & Company Inc (NYSE:MRK), which rose 4.84% or 4.20 points to trade at 90.95 at the close. Meanwhile, Amgen Inc (NASDAQ:AMGN) added 4.57% or 14.79 points to end at 338.45 and Nike Inc (NYSE:NKE) was up 3.87% or 2.35 points to 63.15 in late trade.

The worst performers of the session were NVIDIA Corporation (NASDAQ:NVDA), which fell 2.90% or 5.78 points to trade at 193.27 at the close. Caterpillar Inc (NYSE:CAT) declined 0.51% or 2.92 points to end at 567.93 and Cisco Systems Inc (NASDAQ:CSCO) was down 0.47% or 0.34 points to 71.75.

The top performers on the S&P 500 were Viatris Inc (NASDAQ:VTRS) which rose 10.13% to 11.20, Paramount Skydance Corp (NASDAQ:PSKY) which was up 9.93% to settle at 16.77 and Moderna Inc (NASDAQ:MRNA) which gained 6.74% to close at 26.43.

The worst performers were Enphase Energy Inc (NASDAQ:ENPH) which was down 6.12% to 30.83 in late trade, Vistra Energy Corp (NYSE:VST) which lost 4.84% to settle at 179.16 and Micron Technology Inc (NASDAQ:MU) which was down 4.80% to 241.15 at the close.

The top performers on the NASDAQ Composite were Leifras Co Ltd ADR (NASDAQ:LFS) which rose 596.36% to 11.49, Ridgetech Inc (NASDAQ:RDGT) which was up 76.33% to settle at 3.65 and MSP Recovery Inc (NASDAQ:MSPR) which gained 75.65% to close at 0.56.

The worst performers were Salarius Pharmaceuticals Inc (NASDAQ:SLRX) which was down 51.00% to 0.98 in late trade, Outset Medical Inc (NASDAQ:OM) which lost 48.47% to settle at 6.22 and Vor Biopharma Inc (NASDAQ:VOR) which was down 47.66% to 9.84 at the close.

Rising stocks outnumbered declining ones on the New York Stock Exchange by 1758 to 983 and 80 ended unchanged; on the Nasdaq Stock Exchange, 1796 rose and 1567 declined, while 162 ended unchanged.

Shares in Amgen Inc (NASDAQ:AMGN) rose to all time highs; rising 4.57% or 14.79 to 338.45. Shares in Leifras Co Ltd ADR (NASDAQ:LFS) rose to all time highs; gaining 596.36% or 9.84 to 11.49. Shares in Salarius Pharmaceuticals Inc (NASDAQ:SLRX) fell to all time lows; losing 51.00% or 1.02 to 0.98. Shares in Ridgetech Inc (NASDAQ:RDGT) rose to 52-week highs; up 76.33% or 1.58 to 3.65. Shares in Outset Medical Inc (NASDAQ:OM) fell to all time lows; falling 48.47% or 5.85 to 6.22.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 1.82% to 17.28.

Gold Futures for December delivery was up 0.31% or 12.76 to $4,134.76 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in December rose 1.41% or 0.85 to hit $60.98 a barrel, while the January Brent oil contract rose 1.59% or 1.02 to trade at $65.08 a barrel.

EUR/USD was unchanged 0.23% to 1.16, while USD/JPY rose 0.02% to 154.13.

The US Dollar Index Futures was down 0.13% at 99.33.

Risk Warnings and Disclaimers

Add to Favorites

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51%

Investing.com

Terns Pharmaceuticals

Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Consumer Services, Consumer Goods and Technology sectors led shares higher while losses in the Telecoms, Basic Materials and Industrials sectors led shares lower.

At the close in NYSE, the Dow Jones Industrial Average fell 0.51%, while the S&P 500 index gained 0.10%, and the NASDAQ Composite index climbed 0.34%.

The best performers of the session on the Dow Jones Industrial Average were Amazon.com Inc (NASDAQ:AMZN), which rose 4.13% or 10.08 points to trade at 254.30 at the close. Meanwhile, Boeing Co (NYSE:BA) added 2.19% or 4.40 points to end at 205.42 and NVIDIA Corporation (NASDAQ:NVDA) was up 1.91% or 3.87 points to 206.36 in late trade.

The worst performers of the session were Merck & Company Inc (NYSE:MRK), which fell 3.96% or 3.41 points to trade at 82.58 at the close. Nike Inc (NYSE:NKE) declined 2.84% or 1.84 points to end at 62.76 and Unitedhealth Group (NYSE:UNH) was down 2.51% or 8.58 points to 332.98.

The top performers on the S&P 500 were IDEXX Laboratories Inc (NASDAQ:IDXX) which rose 13.58% to 715.01, Kenvue Inc (NYSE:KVUE) which was up 13.85% to settle at 16.36 and Incyte Corporation (NASDAQ:INCY) which gained 8.26% to close at 101.20.

The worst performers were Kimberly-Clark Corp (NASDAQ:KMB) which was down 14.10% to 102.83 in late trade, Moderna Inc (NASDAQ:MRNA) which lost 8.43% to settle at 24.87 and FMC Corporation (NYSE:FMC) which was down 5.97% to 14.27 at the close.

The top performers on the NASDAQ Composite were MSP Recovery Inc (NASDAQ:MSPR) which rose 159.05% to 0.57, Prelude Therapeutics Inc (NASDAQ:PRLD) which was up 107.55% to settle at 3.30 and Terns Pharmaceuticals Inc (NASDAQ:TERN) which gained 71.91% to close at 14.20.

The worst performers were Uniqure NV (NASDAQ:QURE) which was down 50.27% to 33.66 in late trade, Zooz Power Ltd (NASDAQ:ZOOZ) which lost 45.40% to settle at 0.77 and CURRENC Group Inc (NASDAQ:CURR) which was down 35.98% to 2.42 at the close.

Falling stocks outnumbered advancing ones on the New York Stock Exchange by 1714 to 1030 and 53 ended unchanged; on the Nasdaq Stock Exchange, 2197 fell and 1165 advanced, while 105 ended unchanged.

Shares in IDEXX Laboratories Inc (NASDAQ:IDXX) rose to all time highs; up 13.58% or 85.50 to 715.01. Shares in Kimberly-Clark Corp (NASDAQ:KMB) fell to 5-year lows; down 14.10% or 16.88 to 102.83. Shares in Incyte Corporation (NASDAQ:INCY) rose to 5-year highs; rising 8.26% or 7.72 to 101.20. Shares in FMC Corporation (NYSE:FMC) fell to 5-year lows; falling 5.97% or 0.91 to 14.27. Shares in Amazon.com Inc (NASDAQ:AMZN) rose to all time highs; rising 4.13% or 10.08 to 254.30. Shares in Prelude Therapeutics Inc (NASDAQ:PRLD) rose to 52-week highs; up 107.55% or 1.71 to 3.30. Shares in Terns Pharmaceuticals Inc (NASDAQ:TERN) rose to 3-years highs; gaining 71.91% or 5.94 to 14.20.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 0.40% to 17.37.

Gold Futures for December delivery was up 0.64% or 25.62 to $4,022.12 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in December rose 0.05% or 0.03 to hit $61.01 a barrel, while the January Brent oil contract rose 0.09% or 0.06 to trade at $64.83 a barrel.

EUR/USD was unchanged 0.15% to 1.15, while USD/JPY rose 0.13% to 154.21.

The US Dollar Index Futures was up 0.07% at 99.70.

Risk Warnings and Disclaimers

Add to Favorites

Dj Msp Recovery Inc. (Mspr) Paused Due To Volatility

Reuters